Institutional Ownership Phathom Pharmaceuticals, Inc. (PHAT)
This table provides information about the institutional ownership of Phathom Pharmaceuticals, Inc. (PHAT). We have compiled data on the 149 institutions that hold shares in the stock, with a total of 65.3 Million shares, which have been reported (via 13F filing form) to have a value of $959 Million.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Birchview Capital, LP
Burlington, VT |
Nov 13, 2025 Q3 2025 |
85,000
shares
|
$1.25 Million
0.78% of portfolio
|
Q3 2025
Added 240.0%
|
|
|
Trexquant Investment LP
Stamford, CT |
Nov 14, 2025 Q3 2025 |
78,183
shares
|
$1.15 Million
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Creative Planning
Overland Park, KS |
Nov 14, 2025 Q3 2025 |
78,058
shares
|
$1.15 Million
0.0% of portfolio
|
Q3 2025
Added 36.31%
|
|
|
Exodus Point Capital Management, LP
New York, NY |
Nov 14, 2025 Q3 2025 |
71,275
shares
|
$1.05 Million
0.01% of portfolio
|
Q3 2025
Added 370.59%
|
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 07, 2025 Q3 2025 |
70,258
shares
|
$1.03 Million
0.07% of portfolio
|
Q3 2025
New holding
|
|
|
Penn Mutual Asset Management, LLC
Horsham, PA |
Dec 03, 2025 Q3 2025 |
62,802
shares
|
$922,561
2.21% of portfolio
|
Q4 2022
Reduced 27.76%
|
|
|
Rhumbline Advisers
Boston, MA |
Nov 06, 2025 Q3 2025 |
61,713
shares
|
$906,563
0.0% of portfolio
|
Q3 2025
Reduced 4.41%
|
|
|
Brevan Howard Capital Management LP
St. Helier, Y9 |
Nov 14, 2025 Q3 2025 |
58,097
shares
|
$853,444
0.0% of portfolio
|
Q3 2025
Added 108.73%
|
|
|
Quest Partners LLC
New York, NY |
Nov 03, 2025 Q3 2025 |
54,594
shares
|
$801,985
0.04% of portfolio
|
Q3 2025
Added 69.51%
|
|
|
Xtx Topco LTD
London, X0 |
Nov 14, 2025 Q3 2025 |
54,587
shares
|
$801,883
0.04% of portfolio
|
Q3 2025
Added 280.93%
|
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2025 Q3 2025 |
53,648
shares
|
$788,089
0.0% of portfolio
|
Q3 2025
Added 14.93%
|
|
|
Aqr Capital Management LLC
Greenwich, CT |
Nov 14, 2025 Q3 2025 |
52,629
shares
|
$773,120
0.0% of portfolio
|
Q3 2025
Added 5.42%
|
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2025 Q3 2025 |
45,590
shares
|
$669,717
0.0% of portfolio
|
Q3 2025
Reduced 9.88%
|
|
|
Virtus Investment Advisers, Inc.
Hartford, CT |
Nov 13, 2025 Q3 2025 |
44,306
shares
|
$650,855
0.15% of portfolio
|
Q2 2025
Reduced 1.46%
|
|
|
Adar1 Capital Management, LLC
Austin, TX |
Nov 14, 2025 Q3 2025 |
42,900
shares
|
$630,201
0.05% of portfolio
|
Q3 2025
Reduced 32.36%
|
|
|
Credit Suisse Ag
Zurich, V8 |
May 10, 2024 Q1 2024 |
39,683
shares
|
$582,943
0.0% of portfolio
|
Q1 2024
Added 4.33%
|
|
|
Caxton Associates LLP
London, |
Nov 17, 2025 Q3 2025 |
38,570
shares
|
$566,593
0.01% of portfolio
|
Q3 2025
New holding
|
|
|
Inspirion Wealth Advisors, LLC
|
Oct 06, 2025 Q3 2025 |
36,634
shares
|
$538,153
0.05% of portfolio
|
Q3 2025
Added 84.89%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2025 Q3 2025 |
31,919
shares
|
$468,890
0.0% of portfolio
|
Q3 2025
Added 6.03%
|
|
|
Phar Vision Advisers, LLC
Boca Raton, FL |
Nov 14, 2025 Q3 2025 |
30,968
shares
|
$454,919
0.21% of portfolio
|
Q3 2025
New holding
|
|
|
Commonwealth Equity Services, LLC
|
Oct 22, 2025 Q3 2025 |
30,616
shares
|
$449,749
0.0% of portfolio
|
Q3 2025
Reduced 2.98%
|
|
|
Quadrature Capital LTD
London, X0 |
Nov 13, 2025 Q3 2025 |
30,272
shares
|
$444,695
0.0% of portfolio
|
Q3 2025
New holding
|
|
|
Kera Capital Partners, Inc.
Sacramento, CA |
Oct 27, 2025 Q3 2025 |
30,059
shares
|
$441,566
0.05% of portfolio
|
Q2 2025
Added 0.7%
|
|
|
Occidental Asset Management, LLC
|
Oct 28, 2025 Q3 2025 |
29,672
shares
|
$435,881
0.04% of portfolio
|
Q2 2022
New holding
|
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2025 Q3 2025 |
29,572
shares
|
$434,412
0.0% of portfolio
|
Q3 2025
Added 13.39%
|
|